Clinical Trial Update: TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

This Phase 2 trial update describes evaluating a combination of transarterial chemoembolization (TACE) and tislelizumab in patients with advanced intrahepatic c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Fudan University | Conditions: Intrahepatic Cholangiocarcinoma | Phase 2 | Status: RECRUITING